title: Hypertrophic cardiomyopathy: a heart in need of an energy bar?
abstract: Hypertrophic cardiomyopathy (HCM) has been recently recognized as the most common inherited cardiovascular disorder, affecting 1 in 500 adults worldwide. HCM is characterized by myocyte hypertrophy resulting in thickening of the ventricular wall, myocyte disarray, interstitial and/or replacement fibrosis, decreased ventricular cavity volume and diastolic dysfunction. HCM is also the most common cause of sudden death in the young. A large proportion of patients diagnosed with HCM have mutations in sarcomeric proteins. However, it is unclear how these mutations lead to the cardiac phenotype, which is variable even in patients carrying the same causal mutation. Abnormalities in calcium cycling, oxidative stress, mitochondrial dysfunction and energetic deficiency have been described constituting the basis of therapies in experimental models of HCM and HCM patients. This review focuses on evidence supporting the role of cellular metabolism and mitochondria in HCM.
authors.affiliation: Division of Cardiology, School of Medicine, Johns Hopkins University Baltimore, MD, USA.
authors.forename: Styliani
authors.initials: S
authors.lastname: Vakrou
authors.affiliation: Division of Cardiology, School of Medicine, Johns Hopkins University Baltimore, MD, USA.
authors.forename: M Roselle
authors.initials: MR
authors.lastname: Abraham
keywords: bioenergetic deficit; calcium handling; hypertrophic cardiomyopathy; induced pluripotent stem cells (iPSCs); mitochondria